Journal article
COVID-19 vaccines and kidney disease
Abstract
Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general population, highly potent vaccines should be preferred.
Authors
Windpessl M; Bruchfeld A; Anders H-J; Kramer H; Waldman M; Renia L; Ng LFP; Xing Z; Kronbichler A
Journal
Nature Reviews Nephrology, Vol. 17, No. 5, pp. 291–293
Publisher
Springer Nature
Publication Date
May 2021
DOI
10.1038/s41581-021-00406-6
ISSN
1759-5061